Internal Medicine, Pulmonary Disease · Cambridge, MA
NPI
1568557098
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
4
Medicare group memberships
Hospitals
2
Hospital affiliations
1575 Cambridge Street
Cambridge, MA, 02138
Phone (617) 876-4344
Groups this clinician bills Medicare through
Medicare paid, 2024
$168K
1,594 services
Medicare patients, 2024
711
Average age 80
Drug cost, 2024
$1.1M
16,279 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Maya Berdzenishvili was code 99233 (hospital e&m - subsequent), 312 times for 192 patients. In total Maya Berdzenishvili billed 1,594 services in 17 codes, and Medicare paid $168K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 312 | 192 | $96.49 | $30K |
| 99309 SNF E&M | Facility | 296 | 183 | $88.46 | $26K |
| 99306 SNF E&M | Facility | 275 | 234 | $152.61 | $42K |
| 99310 SNF E&M | Facility | 236 | 149 | $125.75 | $30K |
| 99232 Hospital E&M - Subsequent | Facility | 127 | 68 | $63.97 | $8,124 |
| 99308 SNF E&M | Facility | 114 | 92 | $62.59 | $7,135 |
| 99239 Hospital Discharge Management | Facility | 104 | 103 | $94.33 | $9,810 |
| 99223 Hospital E&M - Initial | Facility | 52 | 52 | $138.86 | $7,221 |
| 99305 SNF E&M | Facility | 46 | 39 | $108.73 | $5,001 |
By year: 2022 $180K for 1,840 services; 2023 $203K for 1,767 services; 2024 $168K for 1,594 services.
Medicare prescription drug claims, 2024
In 2024, the drug Maya Berdzenishvili prescribed most often to Medicare patients was Eliquis (Apixaban), with 837 prescriptions and refills. In total Maya Berdzenishvili wrote 16,279 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 837 | 837 | 96 | $251K |
| Trazodone Hcl Generic | 763 | 763 | 91 | $9,809 |
| Atorvastatin Calcium Generic | 728 | 728 | 143 | $14K |
| Gabapentin Generic | 549 | 550 | 90 | $11K |
| Furosemide Generic | 542 | 542 | 90 | $3,587 |
| Mirtazapine Generic | 504 | 504 | 91 | $13K |
| Levothyroxine Sodium Generic | 452 | 452 | 68 | $6,705 |
| Amlodipine Besylate Generic | 414 | 414 | 83 | $4,688 |
| Metoprolol Succinate Generic | 322 | 322 | 77 | $6,342 |
| Sertraline Hcl Generic | 275 | 275 | 47 | $4,210 |
| Quetiapine Fumarate Generic | 255 | 256 | 32 | $3,801 |
| Metoprolol Tartrate Generic | 255 | 255 | 60 | $2,553 |
| Pantoprazole Sodium Generic | 244 | 244 | 54 | $6,980 |
| Torsemide Generic | 241 | 241 | 39 | $4,237 |
| Tamsulosin Hcl Generic | 224 | 224 | 50 | $5,071 |
Brand drugs: 2,975 claims; generic drugs: 13,291 claims; opioid claims: 166.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Maya Berdzenishvili were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.